WHO calls obesity a chronic disease, endorses GLP-1 drugs with behavioural therapy in fresh guidelines

The World Health Organization has issued its first-ever guidelines for the use of GLP-1 drugs to treat obesity. The WHO has classified obesity as a chronic disease and endorsed the use of these drugs if necessary; however, it has also recommended behavioural changes for sustained impact.

from mint - science https://ift.tt/U2hKxBS
https://ift.tt/5nTYmyV